Breaking News

You are here » Indian-Commodity  :  Commodities  :  Other Commodities  :  Soybean futures trade higher on good demand

30-Apr2018

Soybean futures trade higher on good demand

Soybean futures traded higher on NCDEX, as speculators enlarged their position on account of good demand in the spot market. Soybeans prices are also supported by expectations that the United States will boost its share of the soymeal export market due to harvest shortfalls in Argentina.

The contract for May delivery was trading at Rs 3657.00, up by 0.97% or Rs 35.00 from its previous closing of Rs 3622.00. The open interest of the contract stood at 160020 lots.

The contract for June delivery was trading at Rs 3717.00, up by 1.03% or Rs 38.00 from its previous closing of Rs 3679.00. The open interest of the contract stood at 87930 lots on NCDEX.


Related News

View all news

Nickel futures edge higher on improved demand

Nickel futures edged higher on MCX as participants enlarged their holdings on the back of improved demand from alloy-makers and other consuming industries at the spot market. The contract for October delivery......

Nickel futures edge higher on improved demand

Nickel futures edged higher on MCX as participants enlarged their holdings on the back of improved demand from alloy-makers and other consuming industries at the spot market. The contract for October delivery......

Coriander futures edge higher on improved demand

Coriander futures edged higher on NCDEX as participants built up fresh positions on the back of improved demand at the spot market. Further, tight supplies from major producing regions also fuelled the......

Top News

View all news

Bhansali Engineering Polymers reports 33% fall in Q2 net profit

Bhansali Engineering Polymers has reported results for second quarter ended September 30, 2018.The company has reported 32.71% fall in its net profit at Rs 16.89 crore for the quarter under review as compared......

Biocon, Mylan N.V. receive positive CHMP opinion for Ogivri

Biocon and Mylan N.V. have announced that the European Medicines Agency's Committee for Medicinal Products for Human Use (CHMP) has issued a positive opinion recommending approval of Ogivri, a biosimilar......

Lupin Neurosciences receives positive CHMP opinion for NaMuscla

Lupin Neurosciences, a specialty pharma division of Lupin has announced that the Committee for Medicinal Products for Human Use (CHMP), the scientific committee of the European Medicines Agency (EMA),......